CO5660271A2 - Preparacion de peptidos de somatostatina - Google Patents

Preparacion de peptidos de somatostatina

Info

Publication number
CO5660271A2
CO5660271A2 CO06020917A CO06020917A CO5660271A2 CO 5660271 A2 CO5660271 A2 CO 5660271A2 CO 06020917 A CO06020917 A CO 06020917A CO 06020917 A CO06020917 A CO 06020917A CO 5660271 A2 CO5660271 A2 CO 5660271A2
Authority
CO
Colombia
Prior art keywords
formula
carbon atoms
alkylene
independently
compound
Prior art date
Application number
CO06020917A
Other languages
English (en)
Inventor
Heribert Hellstern
Werner Pachinger
Walter Prikoszovich
Bernhard Wietfeld
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5660271A2 publication Critical patent/CO5660271A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

1.- Un procedimiento para producir un compuesto de la fórmula en donde R1 es alquileno de 2 a 6 átomos de carbono-NR3R4, alquileno de 2 a 6 átomos de carbono-guanidina, o alquileno de 2 a 6 átomos de carbono-COOH en donde cada uno de R3 y R4 es independientemente H, alquilo de 1 a 4 átomos de carbono, ?-hidroxi-alquileno de 2 a 4 átomos de carbono o acilo o R3 y R4 forman junto con el átomo de nitrógeno al que están unidos un grupo heterocíclico, el cual puede comprender un átomo heterogéneo adicional, y R2 es Z1-CH2-R5, -CH-CO-O-CH2-R5,en donde Z1 es O o S y R5 es fenilo opcionalmente substituido, o una sal del mismo,que comprende la ciclización de un análogo de somatostatina lineal de la fórmula IIo la fórmula IlIo la fórmula IVen donde R1 y R2 son como se definieron, cada uno de R11 y R12, independientemente, es un grupo protector amino, por lo que cuando R1 comprende un NH2 terminal, este NH2 terminal también está protegido por el grupo protector amino,y en donde la remoción requerida del grupo(s) protector, y la recuperación de un compuesto de la fórmula I de esta manera se obtiene en forma libre o en la forma de sal.
CO06020917A 2003-08-08 2006-03-02 Preparacion de peptidos de somatostatina CO5660271A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0318682.2A GB0318682D0 (en) 2003-08-08 2003-08-08 Organic compounds

Publications (1)

Publication Number Publication Date
CO5660271A2 true CO5660271A2 (es) 2006-07-31

Family

ID=27839906

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06020917A CO5660271A2 (es) 2003-08-08 2006-03-02 Preparacion de peptidos de somatostatina

Country Status (35)

Country Link
US (1) US7615609B2 (es)
EP (1) EP1654280B8 (es)
JP (1) JP4580928B2 (es)
KR (1) KR101136633B1 (es)
CN (2) CN102127155B (es)
AR (1) AR045327A1 (es)
AT (1) ATE394424T1 (es)
AU (1) AU2004262570B2 (es)
BR (1) BRPI0413437B1 (es)
CA (1) CA2534224C (es)
CO (1) CO5660271A2 (es)
CY (1) CY1108775T1 (es)
DE (1) DE602004013599D1 (es)
DK (1) DK1654280T3 (es)
EC (1) ECSP066352A (es)
ES (1) ES2307039T3 (es)
GB (1) GB0318682D0 (es)
HK (1) HK1090065A1 (es)
HR (1) HRP20080350T3 (es)
IL (1) IL173272A (es)
IS (1) IS2894B (es)
MA (1) MA27982A1 (es)
MX (1) MXPA06001525A (es)
MY (1) MY141731A (es)
NO (1) NO338367B1 (es)
NZ (1) NZ544961A (es)
PE (2) PE20091210A1 (es)
PL (1) PL1654280T3 (es)
PT (1) PT1654280E (es)
RU (1) RU2360921C2 (es)
SI (1) SI1654280T1 (es)
TN (1) TNSN06045A1 (es)
TW (1) TWI345570B (es)
WO (1) WO2005014624A2 (es)
ZA (1) ZA200600584B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2225271B1 (en) * 2007-12-03 2013-07-31 ITALFARMACO S.p.A. New non-selective somatostatin analogues
EP2067786A1 (en) 2007-12-07 2009-06-10 ITALFARMACO S.p.A. Novel non selective analogs of somatostatin
ES2522167T3 (es) 2010-01-05 2014-11-13 National Dong Hwa University Formulación anticancerosa
CN103467575B (zh) * 2013-08-22 2016-03-02 深圳翰宇药业股份有限公司 一种帕西瑞肽的制备方法
CN103641894B (zh) * 2013-12-06 2015-10-28 深圳翰宇药业股份有限公司 一种治疗库欣病的多肽药物的制备方法
EP3233899B1 (en) * 2014-12-19 2020-06-24 Auro Peptides LTD A process for the preparation of pasireotide
CN106188231B (zh) * 2015-05-25 2021-10-22 中国医学科学院药物研究所 帕西瑞肽五肽中间体的合成与应用
CN114621326B (zh) * 2020-12-10 2023-12-26 武汉武药科技有限公司 门冬氨酸帕瑞肽及其中间体和其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3303345A1 (de) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Cyclische peptide mit somatostatin-wirkung
EP0255224A3 (en) 1986-06-30 1990-04-18 Merck & Co. Inc. Cyclic and bridged cyclic somatostatin analogs useful as analgesic agents
US5811512A (en) 1991-08-22 1998-09-22 The Trustees Of The University Of Pennsylvania Non-peptide peptidomimetics and related cyclic hexapeptides
DE69426673T2 (de) 1993-06-23 2001-09-20 Diatide Inc Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung
US5770687A (en) 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
HRP20080350T3 (en) 2008-08-31
KR20060070541A (ko) 2006-06-23
US20060258838A1 (en) 2006-11-16
CY1108775T1 (el) 2014-04-09
EP1654280B1 (en) 2008-05-07
TNSN06045A1 (en) 2007-10-03
KR101136633B1 (ko) 2012-04-18
HK1090065A1 (en) 2006-12-15
RU2360921C2 (ru) 2009-07-10
BRPI0413437B1 (pt) 2017-12-12
CN102127155B (zh) 2013-11-27
EP1654280B8 (en) 2008-08-13
ES2307039T3 (es) 2008-11-16
ECSP066352A (es) 2006-08-30
ZA200600584B (en) 2006-12-27
EP1654280A2 (en) 2006-05-10
PL1654280T3 (pl) 2008-10-31
MY141731A (en) 2010-06-15
IL173272A0 (en) 2006-06-11
IL173272A (en) 2012-03-29
WO2005014624A3 (en) 2005-09-22
MA27982A1 (fr) 2006-07-03
RU2006106721A (ru) 2007-09-20
MXPA06001525A (es) 2006-05-15
AR045327A1 (es) 2005-10-26
CA2534224A1 (en) 2005-02-17
DK1654280T3 (da) 2008-09-29
IS2894B (is) 2014-09-15
IS8338A (is) 2006-03-02
TW200524955A (en) 2005-08-01
PE20091210A1 (es) 2009-09-07
TWI345570B (en) 2011-07-21
US7615609B2 (en) 2009-11-10
CN1832962A (zh) 2006-09-13
DE602004013599D1 (de) 2008-06-19
AU2004262570B2 (en) 2008-06-19
BRPI0413437A (pt) 2006-10-10
ATE394424T1 (de) 2008-05-15
NO338367B1 (no) 2016-08-15
NO20061125L (no) 2006-05-08
WO2005014624A2 (en) 2005-02-17
JP2007526899A (ja) 2007-09-20
AU2004262570A1 (en) 2005-02-17
CA2534224C (en) 2012-03-27
PE20050356A1 (es) 2005-06-17
SI1654280T1 (sl) 2008-10-31
PT1654280E (pt) 2008-08-18
JP4580928B2 (ja) 2010-11-17
CN102127155A (zh) 2011-07-20
NZ544961A (en) 2008-08-29
GB0318682D0 (en) 2003-09-10

Similar Documents

Publication Publication Date Title
CO5660271A2 (es) Preparacion de peptidos de somatostatina
CO5721002A2 (es) Derivados de acido 3-(4-benciloxifenil) propanoico
ECSP034611A (es) Aminotiazoles y su uso como antagonistas del receptor de adenosina
CO6150140A2 (es) Inhibidores de proteina tirosina fosfatasa humana y metodos de uso
PE20051057A1 (es) Fenilalanina-amidas sustituidas por heteroaroilo
TW200606137A (en) Urea derivatives
MX2009010024A (es) Nuevo compuesto de adenina.
TW200800949A (en) Macrocylic inhibitors of hepatitis C virus
PE20050354A1 (es) Aminas ciclicas de bace-1 que poseen un sustituyente heterociclico
PE20091085A1 (es) NUEVOS DERIVADOS DE IMIDAZO[1,2-a]PIRIDINA E IMIDAZO[1,2-b]-PIRIDAZINA
TW200722422A (en) Heterocyclic compound and organic electroluminescent device using the same
UA81468C2 (en) Heteroarylcarbamoylbenzene derivatives
CO5640117A2 (es) Derivados de 2,4-diamonopirimidina
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
AR046201A1 (es) Metodos para preparar derivados 7-(beta-d-ribofuranosilo sustituido en 2'-r1)-4(nr2r3)-5-(etin-1-ilo sustituido)- pirrol[2,3- d]pirimidina
HUP0302825A2 (hu) Lipidben gazdag plakkok csökkentésére szolgáló szerek
PE20050482A1 (es) Derivados de dihidrobenzofuranilo alcanamida
CO5690592A2 (es) 5-arilpirimidinas como agentes anticancer
MY149180A (en) Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof
CO5690589A2 (es) Antagonistas de la hormona concentradora de melanina
MXPA05013584A (es) Compuesto amina terciaria ciclica.
AR060379A1 (es) Compuesto y composicion herbicida
TW200704747A (en) Azaperylenes as organic semiconductors
CO5611125A2 (es) Derivados de azetidina como antagonistas del receptor ccr-3
TW200801023A (en) Substituded phenylethynyl gold-nitrogen containing heterocyclic carbene complex

Legal Events

Date Code Title Description
FG Application granted